Evidence map›Paper›PMID 35943257›Full record

Observational studyMicrobiology spectrum2022

Prevalence, Incidence, and Risk Factors for Intestinal Colonization Due to Fluoroquinolone-Resistant ST131 Escherichia coli: a Longitudinal Study in Highly Dependent, Long-Term Care Facility Residents.

Elena Salamanca-Rivera, Lorena López-Cerero, Jose Manuel Rodríguez-Martínez, Alvaro Pascual, Jesús Rodríguez-Baño

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Regional spread of an atypical ESBL-producingAntimicrobial agents and chemotherapy · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elena Salamanca-Rivera *Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarenagrid.411375.5, Seville, Spain.
Lorena López-Cerero *Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarenagrid.411375.5, Seville, Spain.ORCID 0000-0001-8950-4384
Jose Manuel Rodríguez-MartínezInstituto de Biomedicina de Sevilla and CSIC, Seville, Spain.
Alvaro Pascual *Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarenagrid.411375.5, Seville, Spain.
Jesús Rodríguez-Baño *Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarenagrid.411375.5, Seville, Spain.ORCID 0000-0001-6732-9001
Hospital Universitario Virgen Macarena · ESCentro de Investigación Biomédica en Red · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Escherichia coli ST131 clade C is an important driver for fluoroquinolone resistance (FQ-R). We conducted a prospective observational study in residents from two long-term care facilities (LTCFs) in Seville, Spain, in 2018. Fecal swabs and environmental samples were obtained. E. coli isolates were screened for clade C, FQ-R ST131 by PCR, and molecular typing by PFGE; representatives from pulsotypes were studied by whole-genome-sequencing (WGS) and assigned to lineages (cgSTs). Prevalence of colonization at each time point, incidence density, and risk factors for acquisition were studied. Seventy-six FQ-R ST131 E. coli isolates belonging to 34 cgSTs were obtained; 24 belonging to subclade C1 (116 isolates, 65.9%) and 10 to C2 (60, 34.1%). C1 lineages showed lower virulence scores than C2 (median [IQR], 19 [18 to 20] versus 21 [20 to 21.5],

Indexed as

Escherichia coliEscherichia coli InfectionsAnti-Bacterial Agentsbeta-LactamasesFluoroquinolonesHumansIncidenceLongitudinal StudiesLong-Term CarePrevalenceRisk FactorsAnti-Bacterial Agentsbeta-LactamasesFluoroquinolonesEscherichia colifluorquinolone resistancemultidrug resistancerisk factorsST131

Identifiers

PMID35943257
PMCPMC9431526
OpenAlexW4292401303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.